BAX:NYSE
Baxter International Inc
$23.85
arrow_downward
-0.46%(-0.11) 1D
Oct 8, 2:44:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BAX...
Open
$23.97
High
$24.14
Low
$23.50
Mkt. cap
12.33B
Avg. vol.
6.44M
Volume
1.78M
Dividend
0.17%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$2.07
Beta
0.66
Shares outstanding
517.00M
No. of employees
38K
Open
$23.97
High
$24.14
Low
$23.50
Mkt. cap
12.33B
Avg. vol.
6.44M
Volume
1.78M
Dividend
0.17%
Quarterly dividend
$0.01
Ex-dividend date
Aug 28, 2026
52-wk high
$30.00
52-wk low
$15.73
EPS
-$2.07
Beta
0.66
Shares outstanding
517.00M
No. of employees
38K
News stories
From web sources and news partners
AD HOC NEWS
·
9 hours ago
Barclays starts coverage of Baxter International stock at Underweight
News Corp
·
21 hours ago
Baxter International Inc. stock outperforms competitors despite losses on the day
www.marketscreener.com
·
22 hours ago
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors
Zacks
·
2 days ago
Are Investors Undervaluing Baxter International (BAX) Right Now?
Profile
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
About Baxter International Inc
CEOAndrew Hider
Employees37.5K
Founded1931
HeadquartersDeerfield, Illinois, United States
SectorMedical device
Websitebaxter.com